AudioCure Pharma
Berlin, Germany · Biotechnology, Health Care, Medical
AudioCure Pharma is a Berlin-based start-up focused on developing innovative treatments for sudden hearing loss. The company is currently conducting a Phase 2 clinical trial to test the efficacy of its new compound, AC102. This compound aims to address the unmet medical needs associated with sudden hearing loss, an area characterized by a lack of effective therapies. AudioCure Pharma aspires to ac
Key facts
- Headquarters
- Berlin, Germany
- Employees
- 14
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- www.audiocure.com
- Company page
Recent activity at AudioCure Pharma
AudioCure Pharma funding history
| Date | Round | Amount |
|---|---|---|
| Feb 2025 | Funding Round | Undisclosed |
Leadership
- Christin Galetzka, Director
- Hans Rommelspacher, Chief Scientific Officer
- Reimar Schlingensiepen, Chief Executive Officer
Verified email and direct lines for AudioCure Pharma’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
AudioCure Pharma in the news
- AudioCure Pharma: Novel compound AC102 restores noise-induced hearing loss in preclinical models - News-Medical (Mar 28, 2024)
- A single dose of AC102 restores hearing in a guinea pig model of noise-induced hearing loss to almost prenoise levels - PNAS (Apr 01, 2024)
- Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model - Business Wire (Jul 03, 2025)
- AudioCure Pharma Receives Hearing Technology Innovator Award for its Innovative Compound AC102 for the Treatment of Sudden Hearing Loss - Business Wire (Dec 07, 2023)
Companies similar to AudioCure Pharma
- 52North · Biotechnology, Health Care, Medical
- Radiopharm Theranostics · Biotechnology, Health Care, Medical
- Swarm Oncology Ltd · Biotechnology, Health Care, Medical
- Zest Health · Biotechnology, Health Care, Medical
- Carecubes · Biotechnology, Health Care, Medical
About AudioCure Pharma: questions and answers
What does AudioCure Pharma do?
AudioCure Pharma is a Berlin-based start-up focused on developing innovative treatments for sudden hearing loss. The company is currently conducting a Phase 2 clinical trial to test the efficacy of its new compound, AC102. This compound aims to address the unmet medical needs associated with sudden hearing loss, an area characterized by a lack of effective therapies. AudioCure Pharma aspires to ac
Where is AudioCure Pharma headquartered?
AudioCure Pharma is headquartered in Berlin, Germany.
How many employees does AudioCure Pharma have?
AudioCure Pharma has about 14 employees.
Has AudioCure Pharma raised funding?
Yes. Fundz has recorded 1 funding event for AudioCure Pharma. The most recent, Funding Round of Undisclosed, was in Feb 2025.
Who leads AudioCure Pharma?
Reimar Schlingensiepen is a Chief Executive Officer at AudioCure Pharma.
What is the latest news on AudioCure Pharma?
On Feb 13, 2025, AudioCure Pharma raised an undisclosed amount in a funding round led by InfectoPharm to advance the clinical development of the innovative drug candidate AC102 for sudden hearing loss.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy